HC Surgical Specialists Limited (SGX:1B1)
Singapore
· Delayed Price · Currency is SGD 0.340
0.00 (0.00%)
At close: Dec 5, 2025
HC Surgical Specialists Income Statement
Financials in millions SGD. Fiscal year is June - May.
Millions SGD. Fiscal year is Jun - May.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2020 - 2016 |
| Operating Revenue | 19.11 | 18.81 | 19.08 | 19.31 | 23.36 | Upgrade
|
| Other Revenue | 0.19 | 0.16 | 0.17 | 0.11 | 0.11 | Upgrade
|
| Revenue | 19.3 | 18.97 | 19.25 | 19.42 | 23.47 | Upgrade
|
| Revenue Growth (YoY) | 1.77% | -1.48% | -0.86% | -17.25% | 38.95% | Upgrade
|
| Cost of Revenue | 10.38 | 9.89 | 9.28 | 9.48 | 10.61 | Upgrade
|
| Gross Profit | 8.92 | 9.08 | 9.98 | 9.94 | 12.86 | Upgrade
|
| Selling, General & Admin | 0.03 | 0.02 | 0.02 | 0.06 | -0.16 | Upgrade
|
| Other Operating Expenses | 1.53 | 1.59 | 2.26 | 1.49 | 2.11 | Upgrade
|
| Operating Expenses | 3.49 | 3.65 | 4.03 | 3.22 | 3.66 | Upgrade
|
| Operating Income | 5.43 | 5.43 | 5.95 | 6.72 | 9.2 | Upgrade
|
| Interest Expense | -0.26 | -0.5 | -0.64 | -0.47 | -0.21 | Upgrade
|
| Interest & Investment Income | 0.54 | 0.77 | 0.82 | 0.82 | 0.48 | Upgrade
|
| Earnings From Equity Investments | 0.78 | -0.09 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.84 | -0.45 | 0.29 | 0.53 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | 8.34 | 5.16 | 6.42 | 7.59 | 9.39 | Upgrade
|
| Merger & Restructuring Charges | -0.02 | - | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | -0.68 | -0.75 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.49 | -0.06 | -1.62 | 0.99 | 0.31 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0 | -0.02 | 0 | Upgrade
|
| Asset Writedown | -0 | -0.16 | -0.13 | -0.07 | -0 | Upgrade
|
| Other Unusual Items | - | 0.12 | 0.06 | -0.01 | 0.57 | Upgrade
|
| Pretax Income | 8.8 | 5.06 | 4.05 | 7.75 | 10.27 | Upgrade
|
| Income Tax Expense | 0.02 | 1.12 | 1.07 | 0.94 | 1.41 | Upgrade
|
| Earnings From Continuing Operations | 8.78 | 3.94 | 2.99 | 6.8 | 8.85 | Upgrade
|
| Minority Interest in Earnings | -0.34 | -0.09 | -0.07 | -0.42 | -0.85 | Upgrade
|
| Net Income | 8.44 | 3.85 | 2.92 | 6.38 | 8 | Upgrade
|
| Net Income to Common | 8.44 | 3.85 | 2.92 | 6.38 | 8 | Upgrade
|
| Net Income Growth | 119.42% | 31.76% | -54.25% | -20.25% | 100.65% | Upgrade
|
| Shares Outstanding (Basic) | 154 | 152 | 149 | 149 | 150 | Upgrade
|
| Shares Outstanding (Diluted) | 154 | 152 | 149 | 149 | 150 | Upgrade
|
| Shares Change (YoY) | 0.94% | 2.28% | - | -0.72% | 0.02% | Upgrade
|
| EPS (Basic) | 0.05 | 0.03 | 0.02 | 0.04 | 0.05 | Upgrade
|
| EPS (Diluted) | 0.05 | 0.03 | 0.02 | 0.04 | 0.05 | Upgrade
|
| EPS Growth | 117.39% | 28.82% | -54.25% | -19.68% | 100.61% | Upgrade
|
| Free Cash Flow | 6.75 | 6.23 | 6.51 | 6.84 | 10.24 | Upgrade
|
| Free Cash Flow Per Share | 0.04 | 0.04 | 0.04 | 0.05 | 0.07 | Upgrade
|
| Dividend Per Share | 0.020 | 0.014 | 0.020 | 0.026 | 0.040 | Upgrade
|
| Dividend Growth | 41.43% | -30.00% | -23.08% | -35.00% | 100.00% | Upgrade
|
| Gross Margin | 46.23% | 47.87% | 51.81% | 51.18% | 54.81% | Upgrade
|
| Operating Margin | 28.13% | 28.62% | 30.88% | 34.59% | 39.20% | Upgrade
|
| Profit Margin | 43.72% | 20.28% | 15.16% | 32.85% | 34.09% | Upgrade
|
| Free Cash Flow Margin | 34.95% | 32.85% | 33.82% | 35.20% | 43.63% | Upgrade
|
| EBITDA | 5.87 | 5.92 | 6.39 | 7.22 | 9.69 | Upgrade
|
| EBITDA Margin | 30.40% | 31.24% | 33.17% | 37.20% | 41.30% | Upgrade
|
| D&A For EBITDA | 0.44 | 0.5 | 0.44 | 0.51 | 0.49 | Upgrade
|
| EBIT | 5.43 | 5.43 | 5.95 | 6.72 | 9.2 | Upgrade
|
| EBIT Margin | 28.13% | 28.62% | 30.88% | 34.59% | 39.20% | Upgrade
|
| Effective Tax Rate | 0.24% | 22.17% | 26.35% | 12.19% | 13.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.